These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4863272)

  • 21. [Mutagenesis tests. The problem of antibiotics and chemotherapeutic agents].
    Rodenghi F; Crippa M; Carniti G; Goldstein BP
    G Ital Chemioter; 1982; 29(1):15-9. PubMed ID: 6764432
    [No Abstract]   [Full Text] [Related]  

  • 22. [Review on investigations related to chemical constituents and biological activities of Periplaneta americana].
    He ZC; Peng F; Song LY; Wang XY; Hu MH; Zhao Y; Liu GM
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(21):2326-31. PubMed ID: 18309679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of bruneomycin action.
    Dudnik YV; Gauze GG
    Fed Proc Transl Suppl; 1966; 25(6):1109-12. PubMed ID: 5333659
    [No Abstract]   [Full Text] [Related]  

  • 24. Insensitivity to valine of streptomycin-dependent Escherichia coli K12.
    Polglase WJ
    Mol Pharmacol; 1965 Jul; 1(1):109-12. PubMed ID: 5319648
    [No Abstract]   [Full Text] [Related]  

  • 25. Unchanged antibiotic susceptibility in Escherichia coli and Pseudomonas aeruginosa after long-term in vitro exposure to antineoplastic drugs.
    Kvakkestad KM; Gammelsrud KW; Brandtzaeg P; Høiby EA
    Chemotherapy; 2012; 58(2):118-22. PubMed ID: 22507969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophage induction by N-methyl-N'-nitro-N-nitrosoguanidine.
    Allan RK; McCalla DR
    Can J Microbiol; 1966 Feb; 12(1):202-4. PubMed ID: 5332227
    [No Abstract]   [Full Text] [Related]  

  • 27. Selective inhibition of formation of deoxyribonucleic acid in Escherichia coli by mitomycin C.
    SHIBA S; TERAWAKI A; TAGUCHI T; KAWAMATA J
    Nature; 1959 Apr; 183(4667):1056-7. PubMed ID: 13644283
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of 1-aminocyclopentanecarboxylic acid (NSC-1026) in plasmocytic myeloma.
    MASS RE
    Cancer Chemother Rep; 1963 Apr; 28():17-9. PubMed ID: 13933377
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antimicrobial and antineoplastic properties of alkaloids of greater celandine and their thiophosphamide derivatives].
    Potopal's'kii AI; Akishina TM; Shishka GV
    Mikrobiol Zh; 1975; 37(6):755-9. PubMed ID: 1107767
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolation and characterization of antibiotic-like substances produced by natural Escherichia coli isolates.
    Cavazza ME; Rodriguez Lemoine V
    J Chemother; 1995 Nov; 7 Suppl 4():46-8. PubMed ID: 8904103
    [No Abstract]   [Full Text] [Related]  

  • 31. Resistance and cross-resistance of Escherichia coli mutants to antitumour agent mitomycin C.
    GREENBERG J; MANDELL JD; WOODY PL
    J Gen Microbiol; 1961 Nov; 26():509-20. PubMed ID: 13901477
    [No Abstract]   [Full Text] [Related]  

  • 32. Interactions of antimicrobial agents and antineoplastic agents.
    Yamashiro Y; Fukuoka Y; Yotsuji A; Yasuda T; Saikawa I; Ueda Y
    J Antimicrob Chemother; 1986 Dec; 18(6):703-8. PubMed ID: 3102447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular aspects of chemotherapy].
    Drews J; Eich F; Högenauer G
    Verh Dtsch Ges Inn Med; 1972; 78():361-70. PubMed ID: 4579266
    [No Abstract]   [Full Text] [Related]  

  • 34. Actions of aurintricarboxylate, kasugamycin, and pactamycin on Escherichia coli polysomes.
    Tai PC; Wallace BJ; Davis BD
    Biochemistry; 1973 Feb; 12(4):616-20. PubMed ID: 4570848
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of protein synthesis by bottromycin A2 and its hydrazide.
    Tanaka N; Sashikata K; Yamaguchi H; Umezawa H
    J Biochem; 1966 Oct; 60(4):405-10. PubMed ID: 5339116
    [No Abstract]   [Full Text] [Related]  

  • 36. THE TREATMENT OF MULTIPLE MYELOMA WITH 1-AMINOCYCLOPENTANECARBOXYLIC ACID.
    HELSPER JT; SHARP GS; BENEFIEL WW
    Acta Unio Int Contra Cancrum; 1964; 20():386-8. PubMed ID: 14151938
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutagenic effect of azaserine in relation to azaserine resistance in Escherichia coli.
    IYER VN; SZYBALSKI W
    Science; 1959 Mar; 129(3352):839-40. PubMed ID: 13635022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on antitumor activity, antimicrobial activity and toxicity of phleomycin.
    Ishizuka M; Takayama H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1966 Nov; 19(6):260-71. PubMed ID: 4961685
    [No Abstract]   [Full Text] [Related]  

  • 39. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrimidine reversal of emimycin inhibition of Escherichia coli.
    De Zeeuw JR; Tynan EJ
    J Antibiot (Tokyo); 1969 Aug; 22(8):386-7. PubMed ID: 4899369
    [No Abstract]   [Full Text] [Related]  

    [